Application no. and date | 11189346.7 (espacenet) (Federated) (European Patent Register), 20060411 | Patent/reg. no. and date | DK/EP 2420234, 20130710 | Publication date | 20120222 | Priority no. and date | US 670204 P, 20050411 | EP pub. no. and date |
EP 2420234 20120222 | Effective date | | Applicant/owner | AbbVie Ireland Unlimited Company, 70 Sir John Rogerson's Quay
Dublin 2
Dublin, D02 R296
, IE | Applicant ref. no. | P012894EPDK1 EJ/GB | Inventor | Zhu, Guidong, 1395 Almaden Ln
Gurnee, IL Illinois 60031, US, Gong, Jianchun, 130 Ferndale Rd
Deerfield, IL Illinois 60015, US, Gandhi, Virajkumar, B., 5335 Mahogany Ct.
Gurnee, IL Illinois 60031, US, Penning, Thomas, D., 321 Highview
Elmhurst, IL Illinois 60126, US, Giranda, Vincent, 272 S Fork Dr
Gurnee, IL Illinois 60031, US | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/4184 (2006.01) , A61K 31/454 (2006.01) , A61K 31/55 (2006.01) , A61P 9/10 (2006.01) | Title | 1H-benzimidazol-4-carboxamider substitueret med et kvaternært carbon i 2-stillingen som PARP-inhibitorer til anvendelse ved behandling af cancer | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|